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Abstract
Background—Interventions to impact on the burden of chronic non-communicable diseases, 
such as hypertension and diabetes, include screening of asymptomatic adults, but little is known 
about the subsequent course of clinical care. We report on the uptake of referral for clinical 
assessment and retention in care following a large urban/rural population screening programme in 
Malawi.
Methods—Adult residents were screened for raised blood pressure and raised fasting blood 
glucose at a demographic surveillance site in rural Karonga District and in urban Area 25, 
Lilongwe with well-supported chronic care clinics. Successful uptake was defined as presenting 
for clinical assessment within 6 weeks of referral, and non-attenders were followed at home. 
Logistic regression was used to examine association of uptake with demographic and clinical 
factors. Retention was assessed using survival analysis techniques.
Findings—27,305 participants were screened for hypertension and diabetes between May 2013 
and September 2015. Of these, 4,075 (14.9%) were referred for suspected hypertension (3,640), 
diabetes (172) or both (263). Among those referred, 2,480 (60.9%), reported for clinical 
assessment. Factors associated with uptake of care included being female (adjusted odds ratio 
(aOR):1.40; 95%CI:1.20-1.63), rural residency (aOR:2.24; 95%CI:1.93-2.61), increasing age, 
unemployment (aOR:1.43; 95%CI:1.18-1.74), prior medication, and diabetes. Factors associated 
with better retention in care included final diagnosis with hypertension and/or diabetes following 
clinical assessment, rural residency and older age.
Conclusions—Screening for hypertension and diabetes identifies large numbers of individuals 
who need further clinical assessment, but strategies are needed to ensure better linkage and 
retention into care.
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Introduction
Non-communicable diseases (NCDs) account for 38 million deaths per year globally, 
representing 35.6% of all deaths in adults less than 70 years of age. A large part of this 
burden is in the developing world, including countries in sub-Saharan Africa (SSA), where 
85% of the deaths from NCDs years occur.1, 2 Demographic changes, increasing 
urbanization and lifestyle changes are amongst the contributors to the increasing burden of 
cardio-metabolic risk factors such as diabetes and hypertension.
Combating the massive burden of NCDs, and their complications, in low-income settings 
will require increased and sustained efforts to improve awareness among the public and 
health personnel to enhance detection, access to, and retention in care.3, 4 While health 
systems in SSA have developed mechanisms to manage infectious diseases, there are few 
data on the effect of the increased burden of chronic NCDs on their fragile health systems. In 
Tanzania, as in many SSA countries, outpatient services for NCDs continue to be provided 
at main hospitals, although new policies encourage decentralisation of care to primary level 
health centres and dispensaries.5 In Kenya, management of hypertension and diabetes was 
achievable at the primary care level within an informal setting.6 However, the challenges/
weaknesses in public health systems are evident even in emerging economies, such as South 
Africa.7 Some governments such as Ghana have drafted policies for the prevention and 
control of chronic NCDs although low funding and weak governance have remained 
hindrances.8
Reliable data on the burden of NCDs are lacking from Africa, but some settings have 
reported rates of hypertension and diabetes among adults exceeding 25% and 5%, 
respectively, with little difference between rural and urban settings.9, 10 These disorders, 
whose prevalence are already similar to those in developed countries, and rapidly increasing, 
contribute to at least half of strokes, heart failure and renal failure in SSA.11–15 
Importantly, in these settings, hypertension and diabetes are undetected in the majority of 
subjects, presenting a major impediment to management and necessitating a drive towards 
appropriate screening programmes. However, it will be crucial that screening is coupled with 
an effective route to care, and even less is known about the uptake of care following 
population screening for NCDs in these settings.16
Malawi, like many countries in SSA, needs detailed data to inform the public health 
response to NCDs, with NCDs now the second leading cause of deaths in Malawian adults, 
after HIV/AIDS.17 Cardio-metabolic risk factors, including diabetes and hypertension, have 
been found to be very common in adults following sample surveys. 18, 19 We have recently 
established a research programme to accurately describe the prevalence and risk factors of 
NCDs among adults in both urban and rural areas20 with preliminary analysis showing 
crude prevalence of diabetes and hypertension of 1.5% and 17.2% respectively in the rural 
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area and 2.5% and 20.7% in the urban settings respectively.21, 22 In partnership with the 
Ministry of Health, chronic care clinics (CCCs) have been established in the two areas, 
where individuals suspected to have hypertension and/or diagnosed with diabetes, are 
referred and managed. This has provided a unique opportunity to carefully examine the 
effect of a mass screening programme on uptake and retention in care among patients with 
suspected NCDs. Here, we discuss the enrolment process and factors associated with uptake 
and retention in care, relevant to the SSA setting.
Methods
This work was undertaken at the Malawi Epidemiology and Intervention Research Unit 
(MEIRU), a research partnership between the London School of Hygiene and Tropical 
Medicine (LSHTM), the Malawi College of Medicine and the Ministry of Health (MoH). As 
Karonga Prevention Study, MEIRU has been conducting infectious disease research in rural 
Karonga for over 30 years, and, with the start of the NCD research programme in 2012, has 
established an urban study site in Lilongwe. The NCD work includes large cross-sectional 
studies, at both sites, on the prevalence and risk factors of selected NCDs, including 
hypertension and diabetes, targeting individuals aged 18 years or more. The urban Lilongwe 
site, Area 25, had a population of 54,692 with 34,754 (53.8%) adults aged 18 and above 
following the 2008 population census 23 and was enumerated prior to surveying. In rural 
Karonga, the participants were drawn from the well characterised Demographic Surveillance 
Site (DSS) first set-up in 2002 with a population of over 35,000, 40% of whom, were adults.
24 Before the start of data collection, we undertook active community sensitization 
campaigns. Participants were recruited following a household listing of all eligible residents. 
A questionnaire on lifestyle, physical activity, dietary and economic activities was 
administered to individuals who consented to participate. Anthropometric measurements 
were taken with repeat measurements for weight, height, waist and hip circumference, and 
mid-upper arm circumference (MUAC) among other key physical measurements. Body mass 
index (BMI) was calculated for all participants except pregnant women, and was categorized 
as underweight (<18.5-30 kg/m2), normal (18.5-25), overweight (25-30 kg/m2) and obese (> 
30 kg/m2).
Blood pressure (BP) was measured three times using an Omron automated device with a five 
minute interval between measurements and the average of the last two readings was used.25 
Fasting blood samples were collected by a team of nurses the following morning for 
laboratory measurement of glucose and other metabolic markers (including lipid profiles) 
using Beckman Coulter AU480 Chemistry analysers.
Referral mechanisms
Participants who, on screening, were found to have raised BP (systolic blood pressure (SBP) 
≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg) or those on medication for 
hypertension were referred. Individuals with a fasting blood glucose (FBG) ≥7mmol/L 
(≥126mg/dL) or with a self-report of prior diagnosis of diabetes from a health professional 
were also referred. Referred participants were given a paper referral slip to present at clinic 
and advised to present within two weeks (or sooner for severe hypertension – see below for 
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definition). The referral CCCs were at primary health care facilities; Area 25 Health Centre 
in Lilongwe, and Chilumba Rural Hospital (CRH) in Karonga, where clinical assessment 
and confirmation of diagnosis and subsequent management was provided. Standard MoH 
clinical management guidelines were followed, and additional drugs were provided (through 
a donation from CIPLA, India) to ensure a stable supply.
Clinic procedures
At the CCC, participants were received by a study clerk, who cross-checked referral slips 
and conducted identity checks against a database for those that had forgotten the slip. A 
clinical assessment was conducted by a clinical officer and included repeat BP 
measurements and screening for complications of hypertension or diabetes. Those found to 
have persisting raised BP were managed according to the MoH protocol with lifestyle advice 
only or lifestyle advice plus medication, based on BP severity. BP readings were classed in 
three categories; mild (SBP 140-159 mmHG or DBP 90-99 mmHg), moderate (SBP 
160-179 mmHG or DBP 100-109 mmHg) and severe hypertension (SBP>180 or DBP>110 
mmHg). Participants who, on repeat measurement, no longer met the definition of raised BP, 
were reviewed on three more monthly visits, to determine if the BP remained below 
140/90mmHg. Monthly follow-up appointments were given to all participants enrolled at the 
clinic, with appointment dates recorded in the patient held record (“Health Passport”). 
Individuals failing to respond to lifestyle advice would be started on medication on 
subsequent visits. Management of confirmed diabetic patients also followed MoH guidelines 
on lifestyle management and, where indicated oral medication. Regular checks of FBG were 
done at each visit using point of care glucometers to inform clinical management.
Data linkage
Study identifiers assigned during the initial screening at home, and recorded on referral 
slips, were recorded at the clinic on each visit. The study identifiers were added to the 
clinical review forms completed by the study clinician and study clerk, allowing linkage to 
survey data. On each clinic visit a standardised clinical data slip (including study identifiers) 
was completed and inserted in to the Health Passport, and scanned before departure from the 
clinic.
Uptake of care
Successful uptake was defined as attending clinic for a full clinical assessment within six 
weeks of the date of referral. Those who had not taken up the referral for more than six 
weeks were visited at home and interviewed for reasons for failure to attend.
Retention in care
Retention in care amongst those who attended for the clinical assessment, was defined as 
coming for scheduled clinic appointments until discharge from the clinic or remaining in 
care for the entire follow-up period, whichever was earlier. Participants referred with 
suspected hypertension but whose BP readings did not meet the definition of hypertension 
on three consecutive clinic attendances were excluded from follow-up but still advised to 
have regular BP checks in future. As all patients referred for diabetic care met the case 
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definition, there were no circumstances stopping clinical attendance. Retention in care was 
analysed separately for a) all those with diabetes b) those who still met the definition of 
raised BP on clinical assessment (excluding those with diabetes), and c) those with low, 
normal or only slightly raised BP on the clinical assessment (excluding those with diabetes).
Clinic case load
Clinic case-load of those on anti-hypertensive medication was defined as the number of 
people started on treatment who would still be expected to be attending (expected) and those 
who were still in contact with health services (actual). Still in contact with health services 
was defined as attending the clinic at any time following enrolment regardless of missing 
any appointments in between. This included participants given lifestyle advice only based on 
their BP readings < 140/90 mmHG for the first 3 clinical visits who were subsequently 
started on anti-hypertensive medication later if BP failed to normalise in the subsequent 
visits.
Data management and analysis
Survey data were collected electronically using tablet computers with entry templates 
programmed in the open data kit (ODK) platform. All data were transferred into a database 
at the end of each day. Scans of clinical review forms were double-entered in MS Access.
Logistic regression models were used to assess associations of uptake of care and socio-
demographic factors such as age, sex, study site, occupation, whether they were on 
medication or not, reason for referral, BMI and BP level at screening. Univariate odds ratios 
(ORs) were calculated for the urban and rural sites separately. Adjusted odds ratios (aORs) 
were obtained from a multivariable logistic regression model that included site, sex, age-
group, hypertension/diabetes medication at time of screening, employment (as a surrogate 
for educational status), BMI category (underweight, normal, overweight, obese), referral 
reason and BP level at the time of screening.
Factors influencing retention were explored using Cox proportional hazards regression 
models with Kaplan-Meier plots used to compare retention between sites and within the 
three groups. The multivariable analysis model included group and the other socio-
demographics factors. A participants’ follow-up time was censored at the time of discharge 
from clinic or at the end of the follow-up period whichever was sooner. Failure (drop-out) 
was defined as not attending a scheduled clinical appointment for more than 30 days after 
the appointment date.
Variables where the odds ratios (ORs), hazard ratios (HRs), p-values and 95% confidence 
intervals (CIs) were found significant (p<0.10) in univariate models were included in 
multivariable logistic and Cox models to estimate adjusted odds and hazard ratios 
respectively. Likelihood ratio tests were used in model selection in the multivariable 
analyses. All analyses were done using Stata version 12 (StataCorp Limited, College 
Station, TX).
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Ethics
The study was approved by the Malawi National Health Sciences Research Committee 
protocol number #1072 and the LSHTM ethics committee, protocol number #6303.
Results
Between May 2013 and September 2015, 27,305 adults were screened for hypertension and 
diabetes in Karonga (13,458) and in Lilongwe (13,847). Participation rates are described 
elsewhere [19]. The median age of participants was 31.6 years (inter-quartile range (IQR): 
24.1 – 42.8). 4,075 (14.9%) of all screened participants were referred to the CCCs (14.2% 
and 15.6% for rural and urban, respectively).
Of the individuals referred, 2,480/4,075 (60.9%) reported to the clinic, 1,377 (72.1%) in the 
rural, and 1,103 (51.0%) in the urban site (Figure 1). Around 30% of all referred participants 
were already on hypertension and/or diabetes medication at the time of screening across 
both sites. The majority of those screened and more likely to be referred were female 
(59.6%). At both sites, raised BP and diabetes were much more common in individuals aged 
over 45 years (Table 1).
Factors associated with uptake of clinical services
Rural participants had twice the odds of attending for clinical assessment compared to urban 
participants after adjusting for all other factors (aOR: 2.24; 95% CI: 1.93-2.61). From both 
the site specific univariate analyses and the adjusted model across both sites, female sex was 
also strongly associated with attendance for clinical assessment (aOR: 1.40; 95% CI: 
1.20-1.63). Uptake of care was also higher in older participants. Being already on 
hypertension or diabetes medication was also strongly associated with attendance for care 
(aOR: 1.68; 95% CI: 1.37-2.06) irrespective of site, as was not being in paid employment 
(including unemployed and subsistence farmers) (aOR: 1.43; 95%CI: 1.18-1.74) in the 
adjusted analysis. Within the disease categories, patients referred with diabetes or a 
combination of diabetes and suspected hypertension had significantly greater odds of 
reporting at the clinic than those with suspected hypertension alone (Table 1).
Reasons for non-attendance for clinical assessment
In the rural area 22/170 (12.9%) diabetic patients and 550/1,741 (31.6%) participants with 
suspected hypertension were interviewed at home after non-attendance (572 in total). 96/265 
(36.2%) and 944/1,899 (49.7%) participants with diabetes and suspected hypertension 
respectively in the urban area were also visited (1,040 in total).
Main reasons for not taking up services at the rural site were lack of transport or distance, 
being too busy with work (field activities) and being away from home. At the urban site, the 
main reasons were accessing care at other facilities, being at work (busy) and being away 
from home (Table 2). Of those visited, 214/570 (37%) at the rural site and 258 (25%) at the 
urban did attend for clinical assessment following the home visit.
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Retention in care
Of the 2,480 attending for clinical assessment, based on observations at the clinics 1,551 
(62.5%) were started on medication for diabetes and/or hypertension on the first visit, based 
on survey FBG or repeat BP measurement at clinic. The remaining 929 (37.5%) were given 
lifestyle advice and asked to return for repeat measurements according to treatment 
guidelines. 501/929 (53.9%) of those on lifestyle advice did not have BP above 140/90 
mmHg when repeat measurements were made at the clinic.
At both sites, more than 25% of all participants expected still to be in care were retained 
(and were no more than 30 days late for any scheduled appointment) by 18 months after the 
initial assessment and enrolment in care at the rural and urban sites, Figure 2. The retention 
patterns differed among the three groups; highest among those with diabetes; followed by 
participants with raised BP on clinical assessment (excluding those with diabetes), and those 
with only slightly raised BP on the clinical assessment (excluding those with diabetes) 
(Figure 3). Factors associated with drop-out (failure to be retained in care) included area of 
residency (rural compared to urban, aHR: 0.76; 95% CI: 0.68-0.84), younger age and not 
being on medication prior to screening and referral, Table 3. Unlike with the uptake, sex, 
employment and BMI were all not associated with failure to be retained in care. The rural 
urban differences were only apparent before 3 months, thereafter the drop-out was equal 
across sites (Figure 2)
Examining those in contact with the clinic 24 months into the chronic care programme, 631 
(47.0%) of individuals started on antihypertensive medication were still in contact with the 
CCC out of a cumulative 1,343 (Figure 4), and thus still able to be screened for 
complications and monitored for outcomes, and contributing to clinic case-load. However, 
some would have missed appointments or been absent from clinic for up to six months.
Over the duration of the study, the median number of participants enrolled each month was 
51 (IQR: 32 – 77) while the median monthly clinic attendance including assessment and 
follow-up visits was 512 (IQR: 205 – 650).
Discussion
Efforts at implementing mass screening programmes and care interventions in SSA have 
yielded mixed results. We discuss our own experiences from setting up a large screening and 
care programme for NCDs with comparisons made in uptake and retention of services in 
urban and rural settings.
The uptake of care following the screening was higher at the rural site compared to the urban 
site. The reasons for this discrepancy may include the urban population having more options 
for accessing care (besides the facility they were referred to) than in the rural site. The CRH 
is the only health facility equipped to manage hypertensive and diabetic patients in Karonga 
apart from the district hospital which is 80 kilometres away. Other studies have highlighted 
ease of access to care as one of the challenges to uptake of care. In addition, urban dwellers, 
especially men, were hard to screen and even when screened and enrolled in care would 
miss appointments due to work commitments or other behavioural traits.20 Comparatively, 
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uptake of clinical services for hypertension in rural Uganda was 83% – higher than that in 
our setting at both sites – with older age, female gender and hypertension family history as 
the associated factors. This, was however, after participants were given travel vouchers for a 
clinic appointment.25
More females than males were screened and referred for further management at both sites, 
due to lower participation rates in men. However, even on adjustment women were more 
likely to take up referrals than men.
With respect to age, there were similar patterns in uptake in both rural and urban settings. 
The reasons for this are again unclear in this setting but could include the older participants 
being more concerned about the health consequence of their condition, less able to afford 
alternative care or having more time to travel to appointments.
Participants already on medication may have found the screening programme as an 
opportunity to access care for these conditions within their communities and at a clinic 
where drug supply was guaranteed.
There were contrasting results in uptake with respect to employment. In Lilongwe, uptake 
was lower among those in salaried employment, while in Karonga employment status was 
not associated with uptake of care. The salaried are in a financial position to access care in 
other private health facilities (though health insurance or self-funding) than the unemployed 
in the urban setting. For the rural setting, with CRH being the only place where management 
of such conditions is possible, participants would have little choice but to go to this facility 
regardless of their economic standing.
The perceived seriousness of a health condition influences care-seeking behaviour. This can 
be seen in the better attendance associated with higher levels of BP on screening. The survey 
team explained the meaning of category of screened BP (mild, moderate and severe 
hypertension) and were asked to refer those with severe hypertension urgently. Those 
referred to care for diabetes or diabetes and hypertension showed better uptake of care at 
both sites than those with hypertension only (even after adjusting for age and sex). This 
could also be a result of the perceived seriousness of diabetes as a condition.
Drop-out was lower at the rural site regardless of enrolment reason. We did not investigate 
reasons for attrition among the rural and urban populations although these may be similar to 
the reasons for failure in uptake i.e. distance/transport costs in the rural and other care 
facilities at the urban site. It is interesting that in the rural area there was better retention, 
despite, the cost of repeated visits to the health facility (at a much greater distance than in 
the urban area) in a predominantly subsistence economy which makes long-term attendance 
challenging. This might reflect the fact that CRH was the only site providing such care and 
the rural community being more compliant in general and having a longer and more trusting 
relationship with the research organisation. The urban population would also have other 
treatment options (other nearer/more accessible clinics) if they wished to continue care.
Similar challenges have been reported in setting up NCDs care services in urban Africa, 
with data from slum dwellers of Nairobi in Kenya showing high dropout and non-
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compliance rates.26 Even in rural Cameroon, integrating hypertension and diabetes care in 
non-physician clinics proved feasible but was hampered by low case-detection rates and high 
attrition among patients enrolled into care.27 As with uptake of care, older people were 
more likely to remain in care than younger participants following enrolment. Similarly, 
people who were already on medication prior to screening had higher retention rates 
regardless of the final diagnosis at enrolment, which may reflect self-selection of those 
already willing to take long-term medication.
The management of hypertension and diabetes in a primary care setting within an informal 
settlement showed good retention (68% alive and in care) in Nairobi, Kenya 6. Our findings 
here show that while the retention was lower than that reported by in Kenya, as the majority 
of those started on medication were retained, it may yet have an important clinical impact. 
Already, some interventions to improve retention rates for cardiovascular disease in 
Cameroon via task-shifting in nurse-led rural facilities have seen improved retention rates in 
cardiovascular disease. This was, however, after sending out reminder letters following 
missed appointments.28 A newly rolled out study aims to investigate use of smartphone 
technology among community health workers as a strategy to optimize linkage and retention 
to hypertension care in rural Kenya, and thus, NCD management in low- and middle-income 
countries.29 This, along with other efforts within SSA will provide more insight and lessons 
on possible strategies that might be employed in future to ensure the success of screening 
and care programmes for NCDs.
Previous studies have given inconsistent results about the benefits of mass screening for 
NCDs like hypertension and/or diabetes, and a recent systematic review concluded that 
untargeted screening had no benefits in resource-limited settings.30 However, the reasons 
for this lack of success are unclear, but likely to be complex. One element might relate to 
barriers in linking individuals identified to have high risk or overt disease to care services. 
Our data show that it is feasible to link a screening programme and a clinical service system 
in poor resource country settings, with a reasonable uptake of the services. We will continue 
to explore whether this translates into improved outcomes at a population level.
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Perspectives
We designed and implemented a large screening and care programme for hypertension 
and diabetes in urban and rural Malawi. Screening for hypertension and diabetes 
identified large numbers of individuals requiring further clinical assessment, although a 
large proportion will not take up, or continue to access, care. Uptake of services and 
retention in care were better at the rural compared to the urban site and amongst women 
and older people. Services may need to be made more accessible to employed urban men. 
The longer term clinical outcomes and cost-effectiveness of this programme remain to be 
examined.
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Novelty and Significance
What Is New?
Little little is known about the long-term outcomes among adults diagnosed with 
hypertension and/or diabetes following screening and enrolled in care in SSA.
What Is Relevant?
The effectiveness of screening and care programmes and including observed patterns 
between rural and urban settings.
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Summary
Our findings highlight better uptake and retention of services at the rural site compared to 
the urban population which can access care at other facilities.
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Figure 1. 
Consort diagram showing those screened, identified with hypertension or diabetes, referred 
for care, and attending for care.
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Figure 2. 
Retention in care by site over time
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Figure 3. 
Retention in care following clinical assessment by reason for continuing care
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Figure 4. 
Clinic case-load over time, expected and actual, for patients started on anti-hypertensive 
medication
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Table 2
Main reasons for non-attendance by site
Reason for non-attendance Lilongwe (1,040† participants) Karonga (572† participants)
Attend other facility 149 (14.3%) 47 (8.2%)
Plan to go later 82 (7.9%) 68 (11.9)
Busy at work 220 (21.2%) 67 (11.7%)
Transport costs/distance 0 (0%) 118 (20.6%)
Away for some time 109 (10.5%) 74 (12.9%)
Feeling healthy 39 (3.8%) 29 (5.1%)
Too sick/old 18 (1.7%) 34 (5.9%)
Other (e.g. feeling healthy) 280 (26.9%) 126 (22.0%)
Missing 338 (32.5%) 137 (24.0%)
†
Participants could give more than one reason for non-attendance resulting in total percentages above 100
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Table 3
Hazard Ratios (HRs) for factors associated with drop-out after clinical assessment and 
adjusted Odds Ratios (aHRs) for both sites
Diabetes (+/− hypertension) Hypertension BP not raised on repeat 
measurement at clinic
Overall drop-out
HR (95% CI) HR (95% CI) HR (95% CI) aHR (95% CI) p-value
Diagnosis
Diabetes 1 -
BP medication 1.08 (0.91-1.28) 0.374
BP no medication 1.65 (1.38-1.98) <0.001
Site
Lilongwe 1 1 1 1 -
Karonga 0.72 (0.53-0.99) 0.77 (0.68-0.87) 0.72 (0.60-0.87) 0.76 (0.68-0.84) <0.001
Sex
Male 1 1 1 1 -
Female 1.11 (0.80-1.54) 0.80 (0.70-0.91) 0.79 (0.65-0.95) 0.92 (0.83-1.01) 0.092
Age group
< 25 0.87 (0.21-3.55) 1.85 (1.30-2.62) 1.05 (0.72-1.53) 1.19 (0.92-1.53) 0.182
25 to 45 1 1 1 1 -
45 to 65 0.55 (0.39-0.78) 0.67 (0.57-0.79) 0.66 (0.53-0.81) 0.74 (0.65-0.84) <0.001
65+ 0.44 (0.28-0.69) 0.60 (0.50-0.71) 0.49 (0.38-0.65) 0.69 (0.60-0.80) <0.001
Prior HT/Diabetes meds
Yes 0.49 (0.36-0.67) 0.53 (0.46-0.61) 0.36 (0.28-0.45) 0.49 (0.43-0.55) <0.001
No 1 1 1 1 -
BMI (kg/m2)
Below 18 2.20 (0.79-6.10) 1.01 (0.75-1.37) 1.03 (0.66-1.61)
18 to 25 1 1 1
25 to 30 1.03 (0.71-1.50) 0.84 (0.72-0.97) 1.03 (0.83-1.28)
Above 30 0.80 (0.54-1.18) 0.87 (0.73-1.04) 0.82 (0.63-1.07)
Paid employment
Yes 1 1 1
No 0.85 (0.57-1.29) 0.75 (0.62-0.91) 0.82 (0.63-1.08)
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